Background: Cannabis Clinicians Colorado conducted a Pilot Study on CBD and Quality of Life in Retired Elite Athletes. The study looked at a variety of CBD routes of administration monitored by four data points in a small cohort. As pilot studies investigate feasibility rather than efficacy, this presentation summarizes the data and offers potential areas for further study.
Methods: A placebo-controlled study of cannabidiol (CBD) as a supplement to current therapies in retired elite level athletes with medical issues resulting from their competitive years. 24 subjects received a 60-day supply of either an escalating measured-dose daily CBD supplement or a placebo, in one of six possible routes of administration: capsule, sublingual tincture, sublingual tablet, sublingual nano-emulsified oil, or nasal spray. Subjects underwent twice-monthly monitoring by WAVi QEEG scan, Roberto cognition testing, clinical observation, and e-diary Quality of Life assessment surveys during the study.
Conclusions: The data is promising enough to warrant further study. This was an un-funded study using donated product and a “throwing spaghetti at the wall” approach to routes of administration. Cannabis therapies are well known to fall outside of the conventional medical model of a single chemical compound having a marked effect at a measured dose, so a wide rate of variation was expected.